Blöndal T, Pontén J
Anticancer Res. 1983 Jan-Feb;3(1):47-51.
Fluorometric single cell DNA analysis was performed on 123 tumour samples from 33 patients who had died of small cell carcinoma of the lung (SCCL). In 36% (12 patients) the modal DNA profile was hypodiploid or near diploid and the median survival time was 16.3 months, as opposed to 9.5 months for the 21 patients with hyperdiploid DNA profile, who also seemed to have a lower response rate to chemotherapy. It is suggested that an estimation of the modal DNA ploidy before the start of the treatment in SCCL might be used as a cellular parameter to obtain more comparable treatment study groups and for the prediction of survival.
对33例死于肺小细胞癌(SCCL)患者的123份肿瘤样本进行了荧光单细胞DNA分析。在36%(12例患者)中,模式DNA图谱为亚二倍体或接近二倍体,中位生存时间为16.3个月,而21例DNA图谱为超二倍体的患者中位生存时间为9.5个月,这些超二倍体患者对化疗的反应率似乎也较低。有人提出,在SCCL治疗开始前估计模式DNA倍性,可作为一个细胞参数,以获得更具可比性的治疗研究组,并用于预测生存情况。